Updates and Events
Three Healthcare Organizations Issue Statement on FDA Action to End Emergency Authorization of Medications to Treat COVID-19

June 24, 2020 Joint Statement of the American Medical Association, American Pharmacists Association, and American Society of Health-System Pharmacists on new FDA action to Remove Emergency Use Authorization of Medications to Treat COVID-19 The American Medical Association, American Pharmacists Association, and American Society of Health-System Pharmacists issued a statement “emphasizing that the FDA’s recent announcement to cancel the emergency […] READ MORE

Why People with Lupus Must be More Careful Amid COVID-19

June 9, 2020 This may be hard to believe–since we are currently so immersed in the current pandemic—but COVID-19 and the virus that causes it, SARS-CoV-2, are still brand new. As such, there are many things we don’t know about it yet. But one thing that has been pretty clear from the outset is that […] READ MORE

FDA Revoked Emergency Use Approval of Hydroxychloroquine for COVID-19

June 15, 2020 The U.S. Food and Drug Administration announced June 15 that it revoked approval called emergency use authorization (EUA) for hydroxychloroquine and chloroquine to be used to treat certain patients who had been hospitalized for COVID-19. The FDA made this decision based on its ongoing analysis of the scientific data from current studies […] READ MORE

LRA-Funded Findings Suggest Way to Help Reverse Lupus Nephritis

June 15, 2020 A recently published study explored how an unconventional treatment method undergoing clinical trials in cancer patients could help lessen the severity of lupus nephritis (inflammation of the kidneys), a common and serious condition in people with lupus. Funded by the Lupus Research Alliance, this study, published in the journal, Science Translational Medicine, […] READ MORE

New Guidelines from the ACR For Lupus Care During COVID-19 Pandemic

June 9, 2020 The American College of Rheumatology enlisted 14 experts on infectious diseases and immune system illnesses to develop and publish 25 recommendations on treating lupus and related immune system diseases amid the COVID-19 pandemic.  The Lupus Research Alliance would like to share these with the lupus community as information, but recommend talking to […] READ MORE

A Message From LRA President & Ceo on COVID-19 and Lupus

These are challenging times for everyone-and each of us must stay focused. For the Lupus Research Alliance (LRA) this means safeguarding the health of the lupus community within the new context of the COVID-19 global pandemic. It is imperative that all of us stay calm, safe, and abreast of the most relevant updates on the […] READ MORE

Watch Video of Webcast: Lupus and Cognitive Health

Watch a videotape of our recent webcast: Lupus and Cognitive Health Presented by LRA’s Young Leaders Board People with lupus know only too well the need to avoid stress to prevent flares while optimizing emotional and cognitive wellbeing. But that’s pretty hard to do, especially in this time fraught with societal upheaval amid a global […] READ MORE

Promising News from Major Medical Meeting, EULAR

Updated June 5, 2020 One of the largest meetings for rheumatologists went virtual this year to enable scientists from around the world to share their latest findings amid the COVID-19 pandemic. EULAR, the e-Congress of the European League Against Rheumatism, runs June 3 -6, and LRA is pleased to share promising results from clinical trials […] READ MORE

Lupus Research Alliance Issues Statement June 4, 2020

June 4, 2020 Racism, bigotry, intolerance and violence are hateful and have no place in American society.  The Lupus Research Alliance is committed to ensuring a more caring, loving, equitable and healthy world for those we serve. The lupus community is large and includes a diverse range of racial, religious, ethnic, national and socio-economic groups, […] READ MORE

Learn and connect with our community!